Dr Ford Brewer - PrevMed An OLD Drug that Stops Heart Attacks - Ford Brewer MD MPH - PrevMed Health
10 snips
Apr 14, 2025 Discover how colchicine, an old drug, is making waves in lowering cardiovascular risk and preventing heart attacks. The discussion emphasizes the critical link between inflammation and heart health. Personalized treatment emerges as a key trend, allowing tailored strategies for diabetes and individual risk factors. The alarming statistics reveal a hidden crisis in cardiovascular health, with heart attacks and strokes affecting countless lives, drawing attention to the need for better prevention and management of metabolic diseases.
AI Snips
Chapters
Transcript
Episode notes
Canakinumab Experiment
- Paul Ridker tested Canakinumab, an expensive drug for juvenile arthritis, for its anti-inflammatory properties in cardiovascular disease.
- The study showed a decrease in heart attacks and strokes, confirming inflammation's role.
Cardiology's Plumbing Focus
- Despite evidence pointing to inflammation, cardiology still focuses on plumbing procedures.
- This is partly due to a lack of effective inflammation treatments and financial incentives tied to procedures.
Colchicine's Potential and Hesitation
- Ridker's study on colchicine, a drug derived from the crocus plant, revealed its effectiveness in reducing cardiovascular events.
- Despite this, the cardiology community remained hesitant to adopt it due to side effects and existing treatment protocols.